|
1
|
Dhaliwal G and Mukherjee D: Peripheral
arterial disease: Epidemiology, natural history, diagnosis and
treatment. Int J Angiol. 16:36–44. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fowkes FG, Rudan D, Rudan I, Aboyans V,
Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ,
Mensah GA and Criqui MH: Comparison of global estimates of
prevalence and risk factors for peripheral artery disease in 2000
and 2010: A systematic review and analysis. Lancet. 382:1329–1340.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Song P, Rudan D, Zhu Y, Fowkes FJ, Rahimi
K, Fowkes FG and Rudan I: Global, regional, and national prevalence
and risk factors for peripheral artery disease in 2015: An updated
systematic review and analysis. Lancet Glob Health. 7:e1020–e1030.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Criqui MH and Aboyans V: Epidemiology of
peripheral artery disease. Circ Res. 116:1509–1526. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fowkes FG, Aboyans V, Fowkes FJI,
McDermott MM, Sampson UK and Criqui MH: Peripheral artery disease:
Epidemiology and global perspectives. Nat Rev Cardiol. 14:156–170.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shu J and Santulli G: Update on peripheral
artery disease: Epidemiology and evidence-based facts.
Atherosclerosis. 275:379–381. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dieter RS, Chu WW, Pacanowski JP Jr,
McBride PE and Tanke TE: The significance of lower extremity
peripheral arterial disease. Clin Cardiol. 25:3–10. 2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Olivieri B, Yates TE, Vianna S, Adenikinju
O, Beasley RE and Houseworth J: On the cutting edge: Wound care for
the endovascular specialist. Semin Intervent Radiol. 35:406–426.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Swaminathan A, Vemulapalli S, Patel MR and
Jones WS: Lower extremity amputation in peripheral artery disease:
Improving patient outcomes. Vasc Health Risk Manag. 10:417–424.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kasapis C and Gurm HS: Current approach to
the diagnosis and treatment of femoral-popliteal arterial disease.
A systematic review. Curr Cardiol Rev. 5:296–311. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
McDermott MM, Liu K, Carroll TJ, Tian L,
Ferrucci L, Li D, Carr J, Guralnik JM, Kibbe M, Pearce WH, et al:
Superficial femoral artery plaque and functional performance in
peripheral arterial disease: Walking and leg circulation study
(WALCS III). JACC Cardiovasc Imaging. 4:730–739. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Abu Dabrh AM, Steffen MW, Asi N, Undavalli
C, Wang Z, Elamin MB, Conte MS and Murad MH: Bypass surgery versus
endovascular interventions in severe or critical limb ischemia. J
Vasc Surg. 63:244–253.e11. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bisdas T, Borowski M, Stavroulakis K,
Torsello G and CRITISCH Collaborators: Endovascular therapy versus
bypass surgery as first-line treatment strategies for critical limb
ischemia: Results of the interim analysis of the CRITISCH registry.
JACC Cardiovasc Interv. 9:2557–2565. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Barshes NR, Chambers JD, Cohen J and
Belkin M: Model To Optimize Healthcare Value in Ischemic
Extremities 1 (MOVIE) Study Collaborators: Cost-effectiveness in
the contemporary management of critical limb ischemia with tissue
loss. J Vasc Surg. 56:1015–1024.e1. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Adam DJ, Beard JD, Cleveland T, Bell J,
Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G,
et al: Bypass versus angioplasty in severe ischaemia of the leg
(BASIL): Multicentre, randomised controlled trial. Lancet.
366:1925–1934. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Baird RN, Bradley MD and Murphy KP:
Tibioperoneal angioplasty and bypass. Acta Chir Belg. 103:383–387.
2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Salas CA, Adam DJ, Papavassiliou VG and
London NJ: Percutaneous transluminal angioplasty for critical limb
ischaemia in octogenarians and nonagenarians. Eur J Vasc Endovasc
Surg. 28:142–145. 2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Treiman GS: Subintimal angioplasty for
infrainguinal occlusive disease. Surg Clin North Am. 84:1365–1380,
viii. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Barakate MS, Bannon PG, Hughes CF, Horton
MD, Callaway A and Hurst T: Emergency surgery after unsuccessful
coronary angioplasty: A review of 15 years' experience. Ann Thorac
Surg. 75:1400–1405. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Poyen V, Silvestri M, Labrunie P and
Valeix B: Indications of coronary angioplasty and stenting in 2003:
What is left to surgery? J Cardiovasc Surg (Torino). 44:307–312.
2003.PubMed/NCBI
|
|
21
|
Wohlgemuth WA, Safonova O, Engelhardt M,
Freitag M, Wölfle K and Kirchhof K: Improvement of the quality of
life concerning the health of patients with peripheral arterial
disease (PAD) after successful bypass surgery. Vasa. 37:338–344.
2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Böckler D, Blaurock P, Mansmann U,
Schwarzbach M, Seelos R, Schumacher H and Allenberg JR: Early
surgical outcome after failed primary stenting for lower limb
occlusive disease. J Endovasc Ther. 12:13–21. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nolan BW, De Martino RR, Stone DH,
Schanzer A, Goodney PP, Walsh DW and Cronenwett JL: Vascular Study
Group of New England: Prior failed ipsilateral percutaneous
endovascular intervention in patients with critical limb ischemia
predicts poor outcome after lower extremity bypass. J Vasc Surg.
54:730–735; discussion 735-736. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Uhl C, Hock C, Betz T, Bröckner S, Töpel I
and Steinbauer M: The impact of infrainguinal endovascular
interventions on the results of subsequent femoro-tibial bypass
procedures: A retrospective cohort study. Int J Surg. 13:261–266.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group: Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. PLoS Med.
6(e1000097)2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate health care
interventions: Explanation and elaboration. PLoS Med.
6(e1000100)2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sterne JA, Hernán MA, Reeves BC, Savović
J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT,
Boutron I, et al: ROBINS-I: A tool for assessing risk of bias in
non-randomised studies of interventions. BMJ.
355(i4919)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Viswanathan M, Ansari MT, Berkman ND,
Chang S, Hartling L, McPheeters M, Santaguida PL, Shamliyan T,
Singh K, Tsertsvadze A and Treadwell JR: Assessing the risk of bias
of individual studies in systematic reviews of health care
interventions. In: Methods Guide for Effectiveness and Comparative
Effectiveness Reviews. Agency for Healthcare Research and Quality,
Rockville, MD, 2008.
|
|
29
|
Burns PB, Rohrich RJ and Chung KC: The
levels of evidence and their role in evidence-based medicine. Plast
Reconstr Surg. 128:305–310. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bax L, Yu LM, Ikeda N and Moons KG: A
systematic comparison of software dedicated to meta-analysis of
causal studies. BMC Med Res Methodol. 7(40)2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Higgins JP, Thompson SG and Spiegelhalter
DJ: A re-evaluation of random-effects meta-analysis. J R Stat Soc
Ser A Stat Soc. 172:137–159. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chinn S: A simple method for converting an
odds ratio to effect size for use in meta-analysis. Stat Med.
19:3127–3131. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Rosenthal R: Parametric measures of effect
size. In: The Handbook of Research Synthesis. Russell Sage
Foundation, New York, NY, pp231-244, 1994.
|
|
34
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558.
2002.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Petitti DB: Approaches to heterogeneity in
meta-analysis. Stat Med. 20:3625–3633. 2001.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Duval S and Tweedie R: Trim and fill: A
simple funnel-plot-based method of testing and adjusting for
publication bias in meta-analysis. Biometrics. 56:455–463.
2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bodewes TC, Ultee KH, Soden PA, Zettervall
SL, Shean KE, Jones DW, Moll FL and Schermerhorn ML: Perioperative
outcomes of infrainguinal bypass surgery in patients with and
without prior revascularization. J Vasc Surg. 65:1354–1365.e2.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jones DW, Schanzer A, Zhao Y, MacKenzie
TA, Nolan BW, Conte MS and Goodney PP: Vascular Study Group of New
England: Growing impact of restenosis on the surgical treatment of
peripheral arterial disease. J Am Heart Assoc.
2(e000345)2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Santo VJ, Dargon P, Azarbal AF, Liem TK,
Mitchell EL, Landry GJ and Moneta GL: Lower extremity autologous
vein bypass for critical limb ischemia is not adversely affected by
prior endovascular procedure. J Vasc Surg. 60:129–135.
2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Shi L and Lin L: The trim-and-fill method
for publication bias: Practical guidelines and recommendations
based on a large database of meta-analyses. Medicine (Baltimore).
98(e15987)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hirsch AT, Allison MA, Gomes AS, Corriere
MA, Duval S, Ershow AG, Hiatt WR, Karas RH, Lovell MB, McDermott
MM, et al: A call to action: Women and peripheral artery disease: A
scientific statement from the American heart association.
Circulation. 125:1449–1472. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zachary I and Morgan RD: Therapeutic
angiogenesis for cardiovascular disease: Biological context,
challenges, prospects. Heart. 97:181–189. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Farber A, Rosenfield K and Menard M: The
BEST-CLI trial: A multidisciplinary effort to assess which therapy
is best for patients with critical limb ischemia. Tech Vasc Interv
Radiol. 17:221–224. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Henry M, Henry I, Klonaris C and Hugel M:
Clinical experience with the OptiMed sinus stent in the peripheral
arteries. J Endovasc Ther. 10:772–779. 2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tielliu IF, Verhoeven EL, Zeebregts CJ,
Prins TR, Span MM and van den Dungen JJ: Endovascular treatment of
popliteal artery aneurysms: Results of a prospective cohort study.
J Vasc Surg. 41:561–567. 2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Tunis SR, Bass EB and Steinberg EP: The
use of angioplasty, bypass surgery, and amputation in the
management of peripheral vascular disease. N Engl J Med.
325:556–562. 1991.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Mewissen MW: Self-expanding nitinol stents
in the femoropopliteal segment: Technique and mid-term results.
Tech Vasc Interv Radiol. 7:2–5. 2004.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hossain S, Leblanc D, Farber A, Power AH,
DeRose G, Duncan A and Dubois L: Editor's choice-infrainguinal
bypass following failed endovascular intervention compared with
primary bypass: A systematic review and meta-analysis. Eur J Vasc
Endovasc Surg. 57:382–391. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
PLoS Medicine Editors: Best practice in
systematic reviews: The importance of protocols and registration.
PLoS Med 8: e1001009, 2011.
|
